How Neuroplasticity Can Help You Rewire an Anxious Brain

Share this post:

LinkedIn
Facebook
X
Reddit
WhatsApp
Print

Neuroplasticity is your brain’s ability to change through repeated experience, learning and treatment. In anxiety, that means the same brain that learned fear, overprediction and hypervigilance can also learn calmer responses, better regulation and new patterns of attention over time.

This idea is central to anxiety care because anxiety often feels fixed. You may think the racing thoughts, body tension and threat scanning are just how your mind works. Neuroplasticity says those patterns can become deeply learned, but they are not permanently locked in place. Brain circuits strengthen with repetition. They can also shift with repeated corrective experience.

Your anxious brain does not change all at once. It changes through repeated signals. What you think about, avoid, practice and feel in your body all shape neural pathways. If you rehearse danger every day, your brain gets faster at danger detection. If you practice steadier breathing, reduce avoidance and build new emotional learning through therapy or other forms of treatment, different pathways can strengthen.

That does not mean anxiety is simply a bad habit. Anxiety disorders are real medical conditions with strong biological components. They involve brain circuits tied to fear, attention, memory, stress hormones and body state. Neuroplasticity matters because it explains how those systems can become more rigid and how they can also become more flexible again.

A simple way to think about it is this. Your brain is always learning from what happens often. Chronic anxiety teaches it one kind of lesson. Effective treatment teaches it another.

How chronic anxiety hardwires negative thought loops

Chronic anxiety changes the way your brain predicts threat. Over time, repeated fear responses can make certain pathways more automatic. You may begin to scan for danger before you are even aware you are doing it. A neutral body sensation, delayed text or uncertain plan can trigger the same alarm systems that would be useful in real danger.

Several brain regions are involved in this process. The amygdala helps detect threat and assign emotional salience. The hippocampus helps place experiences in context and links current events with stored memory. The prefrontal cortex supports planning, judgment and regulation. In anxiety, these systems can fall into patterns that favor rapid alarm over careful evaluation.

When anxiety is repeated often enough, your brain gets efficient at it. That is the hardwiring people often talk about. The hardwiring is not a permanent cementing of one state. It is repeated strengthening of certain pathways through use. The brain learns that specific thoughts, situations or sensations deserve priority. It then responds faster the next time.

This helps explain why anxious loops can feel so fast and convincing. You may notice a chest sensation and immediately think something is wrong. You may face a social event and instantly predict embarrassment. You may try to relax and then start scanning for signs that something bad is about to happen. These loops are learned patterns of prediction, attention and body response.

Avoidance strengthens them further. If a situation makes you anxious and you leave it right away, your brain gets a short burst of relief. That relief teaches the brain that escape was necessary. The next time the same cue appears, the alarm may rise even faster. This is one reason anxiety can spread from one situation into many.

Reassurance seeking can do something similar. You feel fear, check for certainty, get brief relief and then repeat the cycle again. The brain learns to depend on checking instead of learning tolerance for uncertainty. That pattern also becomes more automatic through repetition.

The body is part of this learning too. A fast heart rate, tight chest or upset stomach can become conditioned triggers. Once panic has happened a few times, the body sensations themselves can start the next episode. You are not imagining it. Your brain has linked those sensations with danger and now reacts to them quickly.

Sleep loss, chronic stress and trauma can make these loops stronger. A tired or stressed brain has less regulatory capacity. Trauma can leave fear pathways more sensitized and more likely to activate under cues that resemble earlier danger. In those cases, neuroplasticity still matters, but the pathways may be more rigid and more emotionally charged.

The useful part of this science is that the same process that built the loop can also help change it. Repetition shaped the anxious circuit. Repetition can also help build a different one.

Habits and therapies that encourage brain adaptability

Brain adaptability improves when your nervous system gets repeated experiences that differ from the old fear pattern. Change happens best when new learning is practiced consistently and tied to real life situations rather than kept as theory alone.

Exposure based treatment is one of the clearest examples. If you gradually face a feared sensation or situation without escaping, your brain gets new data. It learns that the cue does not always lead to catastrophe. That learning weakens the old prediction and strengthens a different response. This does not erase fear in one step. It changes how the brain scores the cue across time.

Cognitive behavioral work also supports plastic change. When you catch catastrophic thinking, test it against reality and stop feeding the same loop, you are training attention and interpretation. The brain becomes less practiced at automatic worst case prediction and more practiced at flexible evaluation.

Breathing and grounding may seem simple, but they also fit into this model. A slower exhale, less body bracing and stronger contact with the present teach your nervous system that arousal can be regulated. When you repeat these steps often, especially during early signs of anxiety, your brain gets more experience with calming instead of escalating.

Daily routine matters for the same reason. Sleep, movement and regular meals support plasticity because a brain under constant strain changes less efficiently. Chronic exhaustion makes threat circuits louder. Better sleep and steadier body rhythms give the prefrontal cortex and related systems a better chance to regulate emotional responses.

Movement is especially useful because it changes both body state and brain state. Regular exercise can lower baseline stress reactivity, improve sleep and reduce muscle tension. It also gives the nervous system repeated practice moving from activation back toward recovery.

Mindfulness can support adaptability when used consistently. You are training attention to return to the present instead of getting pulled fully into predictions and loops. That shift sounds small. Repeated attention training can have real effects on how quickly your mind gets captured by anxious thought chains.

Social experience also shapes the brain. Safe connection, predictable support and calm communication can help regulate the nervous system. Isolation, high conflict and constant criticism can reinforce threat pathways. Your brain learns from the emotional environment around you.

Therapy works best when it goes past insight alone. Insight can help you name the pattern. Plastic change usually needs experience. That means practicing new responses in real moments, not just talking about them. The brain changes from what you repeatedly do, tolerate and feel, not only from what you intellectually know.

Medication may also support this process for some people. When symptoms are so intense that you cannot engage with therapy or daily practice, reducing symptom load may allow more learning to happen. The deeper mechanism is still learning and neural change. Medication can sometimes create enough room for that learning to take place.

The practical point is simple. Your brain changes in the direction of repeated experience. Habits and therapies work in part because they keep giving your nervous system new experiences often enough for new pathways to hold.

The concept of reopening critical periods in the brain

A critical period is a time during development when the brain is especially open to learning a certain skill or pattern. Early life contains many of these windows. Language, sensory development and social learning all rely on them. During those periods, experience can shape the brain very strongly.

In adulthood, most critical periods are less open than they were in childhood. The brain is still plastic, but usually less flexible than it was early on. That has led researchers to ask an important question. Can certain treatments temporarily increase brain adaptability in adults so that new learning becomes easier and deeper?

This is where the idea of reopening critical periods comes in. The phrase refers to treatments or states that may make the adult brain more receptive to change for a period of time. The concept is still being studied, but it has attracted strong interest in mental health because many chronic conditions involve rigid patterns of thought, emotion and behavior.

For anxiety, that idea is important. If fear pathways have become deeply ingrained, symptom management alone may not always produce enough change. A temporary increase in adaptability could make therapy, emotional learning and behavior change more effective if they happen during that window.

This does not mean the brain becomes childlike again. It means certain aspects of neural learning may become more flexible under specific conditions. Scientists are interested in how this may relate to memory reconsolidation, fear extinction, emotional processing and changes in large scale brain networks.

The concept also helps explain why set and setting, therapeutic guidance and integration are discussed so often in this area of research. If the brain is more open to learning during a window of heightened plasticity, the kind of experience that happens in that window matters a great deal. Random experience may not help much. Structured, emotionally meaningful and well supported experience may have a stronger effect.

This line of thinking also fits with what many people notice clinically. Lasting change often does not come from suppressing every symptom. It comes from changing the deeper relationship between cues, beliefs, emotions and body states. That kind of shift is exactly what plasticity based treatment is trying to support.

You do not need an advanced treatment to benefit from this science. The core idea applies to ordinary care too. Your brain stays capable of change throughout life. Anxiety may have taught it one pattern. Repeated new learning can teach it another. More advanced research is asking how to make that learning deeper, faster and more durable for people whose symptoms have become rigid over time.

As this science continues to develop, we at Rose Hill Life Sciences approach mental health through the lens of neuroplasticity and the brain’s capacity for new learning. We are a psychedelic research organization specializing in the production and research of Psilocybe cubensis, operating at the intersection of science and therapeutic integration, and based in Massachusetts.

Disclaimer: The information in this article is for educational and informational purposes only and does not constitute medical advice.

You May Also Like

Adam Goodman

Advisor

Adam is a seasoned entrepreneur with a wealth of experience in spearheading real estate development and management endeavors. His focus primarily lies in land development, where he orchestrates the intricate tapestry of planning and zoning entitlements, while meticulously overseeing all facets of engineering and architectural design, leasing, construction, and financing.

With a national reach spanning 23 states and encompassing over 250 properties, totaling more than 6 million square feet, Adam’s proficiency in navigating the complexities of the industry is evident.

Beyond real estate, Adam’s endeavors extend into the realm of alternative investments, boasting successful ventures in healthcare, professional sports franchises, financial services, diverse agricultural platforms, and the stewardship of local restaurants.

 

Rotem Petranker, PhD, Psychology

Psychedelic Researcher

Rotem Petranker is a psychedelics researcher with a particular emphasis on microdosing, therapy, research methods and research ethics. He earned his BSc from the University of Toronto, his Master’s degree from York University, and his PhD from McMaster University.

As part of my research, I have gained extensive expertise in navigating the regulatory landscapes of Health Canada and the FDA and a strong background in designing rigorous clinical trial research methodologies. 

I founded the Canadian Centre for Psychedelic Science in 2018, established the Psychedelic Science Research Program at the University of Toronto in 2019, and, more recently, ran the largest clinical trial to date on the effectiveness of microdosing psilocybin for Major Depressive Disorders. I have published many papers on microdosing, including some of the largest samples in the literature and some that have set standards for performing psychedelic research.

Kevin Bourke

Chief Commercial Officer

Kevin Bourke is a dynamic executive and strategic planner whose career spans over two decades of crafting and elevating world-class Jamaican brands and transformational experiences on the global stage. With a keen understanding of culture, identity, and international markets, he has played a pivotal role in shaping some of Jamaica’s most iconic names — including Appleton Estate Rum, Chris Blackwell’s Rum, and Usain Bolt’s Tracks & Records — bringing them from local roots to international acclaim. His leadership and vision have also been instrumental in major cultural movements such as Fiction and the internationally recognized TmrwTday Wellness Festival.

An innovator at heart, Mr. Bourke seamlessly blends brand strategy with deep cultural resonance. His ability to connect with diverse audiences has established these brands not only as commercial successes but as symbolic ambassadors of Jamaican excellence, fortifying the island’s influence in beverage, music, lifestyle, and experiential sectors.

In recent years, Kevin has steered his strategic acumen toward the cutting-edge psilocybin and wellness industry, becoming a co-founder and Chief Marketing and Branding Officer of Rose Hill, Jamaica’s leading cultivator, exporter, and innovator of psilocybin products and experiences. Through ventures like ONE Retreats, he has helped craft safe, guided psychedelic-assisted healing programs that attract participants from around the world seeking deep personal transformation, including military veterans and international wellness seekers.

Kevin’s impact extends beyond business into industry shaping and policy, as he sits on the Jamaica Psilocybin Mushroom Industry Technical Committee (under the Bureau of Standards) — a pivotal body that is formalizing guidelines and regulatory standards for the emerging legal psilocybin sector in Jamaica. His presence on this committee underscores his leadership role in ensuring the industry’s integrity, safety, and sustainable growth.

Highly regarded for his extensive network throughout Jamaica and internationally, Kevin remains passionately committed to advancing ethical, high-integrity product development and customer-centric experiences at every level. His dedication is driven not only by professional achievement but by a deep vision for human well-being, cultural celebration, and the global evolution of plant-based healing.

Jama Pitman

Regulatory Strategy

Jama Pitman is a seasoned biopharmaceutical executive with extensive expertise in global drug development and commercialization. With over two decades of experience, she has contributed to the development of groundbreaking therapies across oncology, rare diseases, and antivirals. As a strategic leader, she has successfully transitioned companies from private to public markets, navigated complex M&A transactions, and driven innovative drug approvals.

Jama has held executive roles in leading organizations, including Deciphera Pharmaceuticals, where she played a pivotal role in scaling operations from a small, privately held biotech company to a global, multi-product company acquired for $2.4 billion. She brings exceptional skills in regulatory affairs, portfolio management, quality assurance, and clinical operations, longside a proven track record of fostering inclusivity and mentorship within her teams.

Currently, as the founder of JP BioPharma Consulting, Jama advises biopharma and tech companies on accelerating drug development and achieving corporate goals. Her collaborative and forward-thinking approach aligns seamlessly with Rose Hill’s mission to advance transformative therapies in mental health and beyond.

Education: B.Sc. in Microbiology, University of New Hampshire.

Notable Achievements: Contributed to the development of multiple FDA-approved therapies, including QINLOCK® for gastrointestinal stromal tumors.

Domenic Suppa

Chief Operating Officer

Domenic is co-founder and the Operations Chief of Rose Hill Health Holdings.

He has been working as a Cannabis technology and operations veteran with more than 11 years’ experience as a senior executive in an operationally complex, and highly regulated industry.

His introduction and entrance into the Cannabis sector started in 2010 with a seed investment into a Denver-based vertically integrated cannabis company called, Evolab. He served as C.O.O. for 5 years from 2013-2018, through the eventual acquisition by Harvest Health and Recreation (HARV: CSE).

Domenic moved on to be acting COO of the manufacturing division for Supreme Cannabis (CSE: FIRE) and supported the acquisition of BLISSCO (CSE: BLISS, a BC-based cannabis manufacturer). Domenic has worked with high-profile national cannabis brands including KKE, and Monogram, and retail brands in MA Native Sun, Terps, and Tilt. Domenic is a proven leader and team builder; his previous experiences have all been with early-stage and growth equity enterprises.

He has refined and evolved his leadership roles, including his team-building skills. He is a value creator. Domenic is a firm believer in training and continuous development. He excels in employing practices, tools, and methodologies designed to achieve maximum process efficiency while minimizing waste and delays.

 

Burton J. Tabaac

Clinical Development

Dr. Burton J. Tabaac, MD, FAHA, brings a wealth of expertise in neurology and stroke rehabilitation to Rose Hill. As an Associate Professor and Section Chief of Neurology at The University of Nevada’s Reno School of Medicine, and Medical Director of Stroke at Carson Tahoe Health, Dr. Tabaac has been at the forefront of innovative neurological treatments.

A graduate of the prestigious cerebrovascular neurology fellowship program at The Johns Hopkins University Hospital, Dr. Tabaac’s accolades include being a three-time recipient of The Arnold P. Gold Foundation’s Humanism and Excellence in Teaching Award and induction into the Alpha Omega Alpha Honor Medical Society.

He recently published an eight-part paper in the American Journal of Therapeutics reviewing psychedelics as therapeutics for primary care clinicians. Dr. Tabaac’s groundbreaking research focuses on the application of psychedelics in brain injury and stroke rehabilitation.

Dr. Tabaac was recently appointed by the Governor of Nevada to serve as a member of the state’s Psychedelic Medicines Working Group, which provides expertise and testimony relating to the therapeutic use of entheogens.

As the host of The Zero Hour Podcast, he engages with leading experts in psychedelic research. His commitment to advancing the field was further highlighted in his 2022 TEDx talk at UCLA, “Mental Health Meets Psychedelics.”

“Joining Rose Hill’s advisory team presents an exciting opportunity to further explore the potential of psilocybin in neurological recovery,” said Dr. Tabaac.

“The company’s commitment to ethical cultivation and research aligns perfectly with my vision for advancing patient care through innovative therapies. I’m eager to bring my expertise to Rose Hill and contribute to the evolving landscape of psychedelic medicine.”

Charles Lazarus

Chief Executive Office

Mr. Lazarus boasts over 16 years of extensive expertise in psilocybin and cannabis, focusing on genetic development, cultivation, extraction, and operations logistics. Notably, he recently achieved a milestone by cultivating and delivering the largest legal shipment of premium psilocybin globally.

As an accomplished owner/operator, Mr. Lazarus has successfully managed multiple farming and harvesting businesses, earning commendations for his unwavering commitment to quality and impressive output volumes. Since 2015, he has been actively involved in producing proprietary psilocybin genetics and cultivation solutions tailored for the Jamaican market and large research and development clients.

His contributions span various aspects, including genetic development, cultivation, extraction, harvest, and logistics. Additionally, Mr. Lazarus owned and operated Island Fresh Ltd., a venture that played a pivotal role in exporting fresh fruit, ground provisions, and promoting brand Jamaica to the English market. Under his leadership, Island Fresh Ltd. achieved the highest volume from Jamaica for three consecutive years.

Mr. Lazarus’s extensive experience also includes serving as the Harvest Manager for cannabis grow operations in California from 2013 to 2017, further solidifying his comprehensive knowledge in the cannabis industry.